A-share innovative drug stocks rallied, with Yaokang Biotech surging over 13% and Lemei Pharmaceutical rising over 8%. Other stocks such as Yinuosi, Harbin Sanlian Pharmaceutical, Borui Pharmaceutical, Hualan Pharmaceutical, and Zhongsheng Pharmaceut

2026-07-22

A-share innovative drug stocks rallied, with Yaokang Biotech surging over 13% and Lemei Pharmaceutical rising over 8%. Other stocks such as Yinuosi, Harbin Sanlian Pharmaceutical, Borui Pharmaceutical, Hualan Pharmaceutical, and Zhongsheng Pharmaceutical also saw gains. In related news, US President Trump announced on social media on July 21 that all generic drugs imported into the US will continue to be subject to zero tariffs for two years, starting August 1, 2026. After the two-year period, a 100% tariff will be imposed on these products for one year; thereafter, the tariff will further increase to 200%.

Other News
2026-07-22

According to Iran's Tasnim News Agency, an explosion was heard in Erbil, Iraq.

2026-07-22

On July 21st, the proportion of A-share stocks with a turnover rate below 3% fell back to 66.52%, remaining in the middle of the fluctuation range since October 2024; the proportion of stocks with a turnover rate above 5% rebounded to 23.74%, remaini